Market Place
Sourcing Support
Correvio Highlights FDA Acceptance of United Therapeutics` Trevyent NDA
11 Sep 2019 //
BIOSPACE
US FDA approves Unity Subcutaneous Delivery System for Remodulin to trear PAH
07 May 2019 //
PHARMABIZ
Sandoz takes United Therapeutics to court for `anticompetitive` behavior
21 Apr 2019 //
BIOPHARMADIVE
United illegally blocked generics to Remodulin, Sandoz suit says
18 Apr 2019 //
FIERCE PHARMA
United kills its PhIII PAH drug after it fails Tyvaso combo study
09 Apr 2019 //
ENDPTS
Generics take aim at United`s top-selling Remodulin
28 Mar 2019 //
FIERCE PHARMA
Rhodes Pharma’s Aptensio Challenged in latest USFDA Para IV Certification List
29 Feb 2016 //
TWOFOUR INSIGHT
United Therap Announces Receipt of Para IV Notice from Actavis for Orenitram
22 Feb 2016 //
TWOFOUR INSIGHT
United Files Citizen Petition Targeting Generics with ANDAs for Tyvaso
23 Jan 2016 //
TWOFOUR INSIGHT
GSK earns expanded approval for Volibris in Europe
26 Nov 2015 //
PM LIVE
United Therapeutics, Novartis Settle Dispute Over Generic Remodulin
30 Sep 2015 //
NASDAQ
Gilead and GSK pulmonary hypertension drugs work in tandem
28 Aug 2015 //
PM LIVE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.